MILTENYI BIOTEC

Company Snapshot

Founded: 1989
Entity Type: Private
Employees: 4700
Region: Germany
Headquarter: Bergisch Gladbach, Germany
Key Geographics: Germany
Corporate Address: Friedrich-Ebert-Straße 68 51429 Bergisch Gladbach Germany Tel. +49-2204-8306-0 www.miltenyibiotec.com

Company Overview

Founded in 1989, Miltenyi Biotec develops products and solutions for the advancement of biomedical research and to enable cell and gene therapy. The company offers more than 19,000 products and services in the field of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis and preclinical imaging. Miltenyi Biotec also offers scientific support, consultation and expert training. Miltenyi markets its products in 68 countries and has offices in 29 global locations.

Miltenyi Biotec’s flow cytometry portfolio includes instruments, reagents, kits and software for cell sorting and cell analysis. The company also offers customized reagents solutions, such as antibodies and conjugates tailored to clients’ specifications.

Miltenyi Biotec’s key technology offerings include its MAgnetic Cell Separation (MACS) technology for cell sorting and cell analysis. The company’s MACS technology uses MACS microbeads, MACS columns and MACS separators for magnetic cell separation. Miltenyi Biotec also offers industrial services, including contract manufacturing of reagents and disposables for the CliniMACS cell separation system (i.e., an automated cell selection device based on MACS technology), cell culture and solutions.

MILTENYI BIOTEC In Reports

Global Cell Line and Membrane Market

According to BCC Research Cell Line and Membrane Market report includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through 2030.

Global Markets for Media, Sera and Reagents in Biotechnology

BCC Research Report: Dive into Media Sera and Reagents in Biotechnology market report considers 2023 as the base year and the forecast years 2024 through 2029.

High Content Screening/Imaging: Technologies and Global Markets

BCC Research Market Analyst says global market for high content screening and imaging is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029 at a CAGR of 8.4%.

Applications/End User Industries

  • Immunology
  • Stem Cell Research
  • Oncology
  • Cell and Gene Therapy
  • Neuroscience
  • Cardiovascular
  • Immuno-Oncology
  • Hematopoietic
  • Mesenchymal Stem Cells
  • Tumor Cell
  • Isolation
  • Neurons
  • Neuroscientists
  • Microglia